| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Suzanne Crowe is Director at RCEL. Suzanne Crowe's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
Net of sales, the RCEL filings show accumulation of 1,552 shares.
Suzanne Crowe has 8 Form 4 filings on record from September 2021 to June 2026, all as Director at AVITA Medical (RCEL), 2021–2026.
The 14 reported transactions were 6 stock awards, 6 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $25K and no sales.
The largest open-market purchase was 1,066 shares of RCEL at an average $17.08 on September 20, 2021, about $18K. Twelve months later RCEL was down 66%.